Patient Portal

Tarek Alhamad, MD, MS

Assistant Professor, Medicine
Division of Nephrology

Specialty Areas

Nephrology
Kidney Transplantation
Dialysis Management

Board Certifications

Internal Medicine
Nephrology

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Antibody mediated rejection, simultaneous pancreas and kidney transplantation, high risk kidney transplantation, recurrent glomerulonephritis.

  • Location(s)
  • Education
  • Publication & Research
  • Financial Disclosures

Location(s)

Location(s)

Center for Advanced Medicine
Medicine Multispecialty Center

4921 Parkview Place
St. Louis, MO 63110

Suite: C
Floor: 5
Office Phone: 314-362-5365
Fax: 314-362-5470

Fresenius Medical Care Metro - Normandy

25 North Oaks Plaza
Normandy, MO 63121
Phone: 314-389-4105

Education

Education

Fellowship, Transplant Nephrology: Mayo Clinic, Scottsdale, AZ 2014
Fellowship, General Nephrology : Penn State College of Medicine, Penn State University, Hershey, PA 2013
MS, Public Health Science: Penn State University, Hershey, PA 2013
Residency, Internal Medicine: Texas Tech University Health Sciences Center, El Paso, TX 2011
Medical Degree: University of Damascus, Damascus, Syria 2005

Publication & Research

Publication & Research

Three-Month Pancreas Graft Function Significantly Influences Survival Following Simultaneous Pancreas-Kidney Transplantation in Type 2 Diabetes Patients.
Alhamad T, Kunjal R, Wellen J, Brennan DC, Wiseman A, Ruano K, Hicks V, Wang M, Schnitzler MA, Chang SH, Lentine KL
Am J Transplant. 2019 Sep 25; doi: 10.1111/ajt.15615.

PMID:
    31553823
    [PubMed - as supplied by publisher]
Related citations


Poor Outcomes with the Use of Checkpoint Inhibitors in Kidney Transplant Recipients.
Venkatachalam K, Malone AF, Heady B, Delos Santos R, Alhamad T
Transplantation. 2019 Aug 9; doi: 10.1097/TP.0000000000002914.

PMID:
    31415036
    [PubMed - as supplied by publisher]
Related citations


Perceptions and Practices Regarding Frailty in Kidney Transplantation: Results of A National Survey.
McAdams-DeMarco MA, Rasmussen SEVP, Chu NM, Agoons D, Parsons RF, Alhamad T, Johansen KL, Tullius SG, Lynch R, Harhay MN, Rao MK, Berger J, Cooper M, Tan JC, Cheng XS, Woodside KJ, Parajuli S, Lentine KL, Kaplan B, Segev DL, Kobashigawa JA, Dadhania D, *On behalf of the AST Kidney Pancreas Community of Practice Workgroup.
Transplantation. 2019 May 7; doi: 10.1097/TP.0000000000002779.

PMID:
    31343576
    [PubMed - as supplied by publisher]
Related citations


Center-Related Variation in Cardiac Stress Testing in the 18 Months Prior to Renal Transplantation.
Shpigel AA, Saeed MJ, Novak E, Alhamad T, Rich MW, Brown DL
JAMA Intern Med. 2019 May 13; doi: 10.1001/jamainternmed.2019.0423.

PMID:
    31081860
    [PubMed - as supplied by publisher]
Related citations


Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes.
Alhamad T, Koraishy FM, Lam NN, Katari S, Naik AS, Schnitzler MA, Xiao H, Axelrod DA, Dharnidharka VR, Randall H, Ouseph R, Segev DL, Brennan DC, Devraj R, Kasiske BL, Lentine KL
Transplantation. 2019 Feb 4; doi: 10.1097/TP.0000000000002599.

PMID:
    30747847
    [PubMed - as supplied by publisher]
Related citations


Racial/Ethnic Disparities in Access and Outcomes of Simultaneous Liver-Kidney Transplant Among Liver Transplant Candidates With Renal Dysfunction in the United States.
Chang SH, Wang M, Liu X, Alhamad T, Lentine KL, Schnitzler MA, Colditz GA, Park Y, Chapman WC
Transplantation. 2019 Aug; 103(8)1663-1674. doi: 10.1097/TP.0000000000002574.

PMID:
    30720678
    [PubMed - in process]
Related citations


The association of preoperative cardiac stress testing with 30-day death and myocardial infarction among patients undergoing kidney transplantation.
Dunn T, Saeed MJ, Shpigel A, Novak E, Alhamad T, Stwalley D, Rich MW, Brown DL
PLoS One. 2019; 14(2)e0211161. doi: 10.1371/journal.pone.0211161.

PMID:
    30707723
    [PubMed - in process]
Related citations


Repeat kidney transplant recipients with active rejection have elevated donor-derived cell-free DNA.
Mehta SG, Chang JH, Alhamad T, Bromberg JS, Hiller DJ, Grskovic M, Yee JP, Mannon RB
Am J Transplant. 2019 May; 19(5)1597-1598. doi: 10.1111/ajt.15192.

PMID:
    30468563
    [PubMed - in process]
Related citations


Safety and efficacy of patiromer use with tacrolimus in kidney transplant recipients.
Rattanavich R, Malone AF, Alhamad T
Transpl Int. 2019 Jan; 32(1)110-111. doi: 10.1111/tri.13369.

PMID:
    30444015
    [PubMed - indexed for MEDLINE]
Related citations


Center-driven and Clinically Driven Variation in US Liver Transplant Maintenance Immunosuppression Therapy: A National Practice Patterns Analysis.
Nazzal M, Lentine KL, Naik AS, Ouseph R, Schnitzler MA, Zhang Z, Randall H, Dharnidharka VR, Segev DL, Kasiske BL, Hess GP, Alhamad T, McAdams-Demarco M, Axelrod DA
Transplant Direct. 2018 Jul; 4(7)e364. doi: 10.1097/TXD.0000000000000800.

PMID:
    30046654
    [PubMed]
Related citations


ACTH Gel in Resistant Focal Segmental Glomerulosclerosis After Kidney Transplantation.
Alhamad T, Manllo Dieck J, Younus U, Matar D, Alasfar S, Vujjini V, Wall D, Kanawati B, Reiser J, Brennan DC, Alachkar N
Transplantation. 2019 Jan; 103(1)202-209. doi: 10.1097/TP.0000000000002320.

PMID:
    29894413
    [PubMed - indexed for MEDLINE]
Related citations


Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data.
Vest LS, Koraishy FM, Zhang Z, Lam NN, Schnitzler MA, Dharnidharka VR, Axelrod D, Naik AS, Alhamad TA, Kasiske BL, Hess GP, Lentine KL
Clin Transplant. 2018 Aug; 32(8)e13302. doi: 10.1111/ctr.13302.

PMID:
    29851159
    [PubMed - in process]
Related citations


The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes.
Axelrod DA, Schnitzler MA, Alhamad T, Gordon F, Bloom RD, Hess GP, Xiao H, Nazzal M, Segev DL, Dharnidharka VR, Naik AS, Lam NN, Ouseph R, Kasiske BL, Durand CM, Lentine KL
Am J Transplant. 2018 Oct; 18(10)2473-2482. doi: 10.1111/ajt.14895.

PMID:
    29701909
    [PubMed - in process]
Related citations


Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes.
Lentine KL, Lam NN, Naik AS, Axelrod DA, Zhang Z, Dharnidharka VR, Hess GP, Segev DL, Ouseph R, Randall H, Alhamad T, Devraj R, Gadi R, Kasiske BL, Brennan DC, Schnitzler MA
Am J Transplant. 2018 Dec; 18(12)2987-2999. doi: 10.1111/ajt.14714.

PMID:
    29498196
    [PubMed - in process]
Related citations


An economic assessment of contemporary kidney transplant practice.
Axelrod DA, Schnitzler MA, Xiao H, Irish W, Tuttle-Newhall E, Chang SH, Kasiske BL, Alhamad T, Lentine KL
Am J Transplant. 2018 May; 18(5)1168-1176. doi: 10.1111/ajt.14702.

PMID:
    29451350
    [PubMed - in process]
Related citations


Metastatic melanoma after solid organ transplantation: An interdisciplinary, institution-based review of management with systemic and targeted therapies.
Tripathi SV, Morris CR, Alhamad T, Fields RC, Linette GP, Cornelius LA
J Am Acad Dermatol. 2018 Jan; 78(1)184-185. doi: 10.1016/j.jaad.2017.06.031.

PMID:
    29241778
    [PubMed - indexed for MEDLINE]
Related citations


Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice.
Dharnidharka VR, Naik AS, Axelrod DA, Schnitzler MA, Zhang Z, Bae S, Segev DL, Brennan DC, Alhamad T, Ouseph R, Lam NN, Nazzal M, Randall H, Kasiske BL, McAdams-Demarco M, Lentine KL
Transpl Int. 2018 Feb; 31(2)198-211. doi: 10.1111/tri.13079.

PMID:
    28987015
    [PubMed - indexed for MEDLINE]
Related citations


Reexamining the Association of Body Mass Index With Overall Survival Outcomes After Liver Transplantation.
Chang SH, Liu X, Carlsson NP, Park Y, Colditz GA, Garonzik-Wang JM, Chapman WC, Wellen JR, Doyle MB, Alhamad T
Transplant Direct. 2017 Jul; 3(7)e172. doi: 10.1097/TXD.0000000000000681.

PMID:
    28706975
    [PubMed]
Related citations


Targeting High Calcineurin Inhibitor Levels After Acute Rejection With Less Tremor: A New Strategy.
Alhamad T, Venkatachalam K, Daloul R, Brennan DC, Malone AF
Transplantation. 2017 Aug; 101(8)e287-e288. doi: 10.1097/TP.0000000000001797.

PMID:
    28422926
    [PubMed - indexed for MEDLINE]
Related citations


The Privilege of Induction Avoidance and Calcineurin Inhibitors Withdrawal in 2 Haplotype HLA Matched White Kidney Transplantation.
Brifkani Z, Brennan DC, Lentine KL, Horwedel TA, Malone AF, Delos Santos R, Maw TT, Alhamad T
Transplant Direct. 2017 Mar; 3(3)e133. doi: 10.1097/TXD.0000000000000645.

PMID:
    28361117
    [PubMed]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2018:

Company Name: Sanofi

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $10,000 - $19,999

Reporting Date: May 01, 2019


Company Name: Veloxis

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $10,000 - $19,999

Reporting Date: May 01, 2019

Notes

Simultaneous pancreas and kidney transplantation, donation after cardiac death, immunosuppression minimization.